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ABSTRACT
‘Excitotoxicity’ represents the excitatory amino acid mediated degeneration of neurons.
Glutamate is the major excitatory neurotransmitter in the brain. Glutamate excitotoxicity has
been implicated in a number of neurodegenerative disorders like Stroke, Epilepsy, Alzheimer’s
disease and traumatic brain injury. This neurotoxicity is summed up by the ‘glutamate
hypothesis’ which describes the cause of neuronal cell death as an excessive release of glutamate
causing over excitation of the glutamate receptors and subsequent increase in influx of calcium
leading to cell death. An effort to counteract this neurotoxicity has lead to the development of
glutamate receptor antagonists that can effectively serve as neuroprotective agents. Nevertheless,
the downside to these drugs has been the side effects observed in clinical trial patients due to
their disruptive action on the physiological function of these receptors like learning and memory.
This work was undertaken to identify targets that can effectively be used to treat
excitotoxicity without affecting any normal physiological functions. In one approach, (chapter I)
we have identified the KATP channels as an effective modulator of epileptogenesis. In another
approach, (Chapter II) we show that targeting the AMPA receptor subunit GluR2 is a practical
strategy for stroke therapy.
KATP channels that are gated by intracellular ATP/ADP concentrations are a unique
subtype of potassium channels and play an essential role in coupling intracellular metabolic
events to electrical activity. Opening of KATP channels during energy deficits in the central
nervous system (CNS) induces efflux of potassium ions and in turn hyperpolarizes neurons.
Thus, activation of KATP channels is thought to be able to counteract excitatory insults and
protect against neuronal death. Here, we show that, functional Kir6.1 channels are located at
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excitatory pre-synaptic terminals as a complex with type-1 Sulfonylurea receptors (SUR1) in the
hippocampus. The mutant mice with deficiencies in expressing the Kir6.1 or the SUR1 gene are
more vulnerable to generation of epileptic form of seizures, compared to wild-type controls.
Whole-cell patch clamp recordings demonstrate that genetic deletion of the Kir6.1/SUR1
channels enhances glutamate release at CA3 synapses. Hence, expression of functional
Kir6.1/SUR1 channels inhibits seizure responses and possibly acts via limiting excitatory
glutamate release.
In addition to epilepsy, ischemic stroke is a leading cause of death in developed
countries. A critical feature of this disease is a highly selective pattern of neuronal loss; certain
identifiable subsets of neurons, particularly CA1 pyramidal neurons in the hippocampus are
severely damaged, whereas others remain intact. A key step in this selective neuronal injury is
Ca2+/Zn2+ entry into vulnerable neurons through α-amino-3-hydroxy-5-methyl-4-isoxazole
propionic acid (AMPA) receptor channels, a principle subtype of glutamate receptors. AMPA
receptor channels are assembled from glutamate receptor (GluR) -1, -2, -3, and -4 subunits.
Circumstance data have indicated that the GluR2 subunits dictate Ca2+/Zn2+ permeability of
AMPA receptor channels and gate injurious Ca2+/Zn2+ signals in vulnerable neurons. Here we
show that ischemic insults induce toxic Ca2+ entry through AMPA receptors into vulnerable
neurons by modification of GluR2 RNA editing. Thus, targeting of GluR2 subunit can be
considered as a promising target for stroke therapy.

iv

Dedicated to

my amma and appa
Without their love, support and nurture this amazing process would have been impossible. Their
role in my life has been a tremendous influence on all my accomplishments. I carry the values
and strength I draw from them as I jump over every fence.

v

ACKNOWLEDGMENTS
My foremost thanks to my advisor, Dr YouMing Lu. Without his guidance, support and
unbelievable patience my PhD would not have been possible. He has been there every single
time I needed him. His mentoring has shown me my strengths, corrected my imperfections and
has helped me develop as a scientist. I thank him for showing me the fun in doing science and for
teaching me, happiness is indeed possible in science. Chief, you have been an inspiration and I
hope one of these days I measure up to you. My research was supported by the NIH/NINDS
grants RO1NS051383 and AHA grants 69018001, 69018006 to Dr Lu.
Thanks to my committee members Dr Pappachan Kolattukudy, Dr Steven Chan and Dr
Ella Bossy-Wetzel for their constructive criticisms. I especially thank Dr Chan and Dr BossyWetzel for playing a special part in my scientific development through the journal clubs and the
discussions during the course of my PhD.
I sincerely thank my lab colleagues Lisheng Peng, for being my friend and answering my
million questions. Xiaofen Zhong, for all the hardship, it took her to make me understand
electrophysiology and for trying to teach me Chinese at which she failed miserably. Their
camaraderie has showed me the importance and value of having an approachable senior in the
lab. I thank WeiHong Tu and Wu Di for their help and encouragement. I thank all of them for
accepting me, tolerating my craziness and doing their best everyday to make me feel I am one of
them.
I thank Dr Tony Zervos for taking me in and guiding me through my baby steps when I
was so far away from everything that was familiar. Thanks to Lucia Cilenti for being a friend and
for her patience when I thought “minnie” prep was a Disney character. The time I spent at the

vi

Zervos lab was essential for my realization for what I really want to do in science. My special
thanks to Dr Laurence Von Kalm, who served as a member in my committee. His support and
fairness has helped me through the toughest times of my PhD. My thanks to Dr William Self and
Dr Annette Khaled for being in my first committee.
Throughout this process at UCF, exceptional people have pushed me forward and
encouraged me in so many ways. My friends, Arul Sahadevan and Raja Ganesan for the endless
hours they listened to my complaints and the endless times they told me it will be all right. I
thank them for helping me keep my belief in this process; Nitya Venkataraman, for the various
ways she brought home so close; Valerie Stratico, who was my “go to girl” in my efforts to
adjust to strange America. Matching her “expertise” in the lab and dressing up with her for
Halloween has been some of the happiest times of my PhD; Todd Castoe, who in his “infinite
beer-derived wisdom” knew the right things to say every time to make me bounce back. I will
always miss the countless hours I have spent around his table shedding blood over our course
work. Above all, I thank him for surviving and showing me how insignificant a failed
experiment was. I thank, Pamela Bagsiyao for her support, the countless runs, lunches and small
talk that helped me come back to deal with the every day chaos; Gero Nootz, who was late for
the party, but stuck with me to the very end and helped me with so many things personal and
academic. I thank, Roman Nemec, for being there for me, for teaching me that determination
helps survive the toughest times and for the countless times he fixed the cars I crashed. His
remarkable come back has helped me to develop a greater appreciation for my work and to
realize it is worth the pain; Pierre Decayette, who dreaded my phone calls but answered every
one of them. I thank my friends, Mahua Chaudhury, Raja Kanagaraj, Sarath Dhananjayan, Priya

vii

Ramamoorthy, Max Chen, Claudia Romero, David Moe and Anita Ellappan for helping to pull
me through. I thank these people for their loyalty, passion and presence whenever I needed them.
I thank Ms. Kitty and Ms. Sue for the music they have brought into my life that changed
my everyday despair into everyday success. I thank my instructors at Butokukan UCF, Mr. Gary
Cox, Mr. Stanley Wreblewski, Mr. Rick Vallaro, Rusty Fadgen, Rory Mulcahy and the number
of other fellow students whose skills and friendship has enriched my experience at UCF.
It is very difficult to thank my family enough for all they have been to me through out my
life and especially this tedious process. I thank my uncle S.P. Swamy for his belief in me and
being my model for success; my uncle Jayaseelan Krishnamoorthy for his trust, encouragement
and constantly reminding me that I can do this; my brother Suresh Raman, who has been my
leaning pole all through these years and for trouble shooting my life every single day. I owe so
much to his love, advice and moral support. My aspiration to improve is largely my constant
effort to catch up with him; my brother Siva Swamy, one of the most incredible people in my
life, for trusting that somebody who comes up with “calcometer” could get her PhD. I am
indebted to him for initiating a process that has changed me in so many aspects. I thank him for
being there since my “full-time GRE student days” to “my paper is published days”; my little
sister, my best friend, Shenbaga Soundarapandian for all the times she cheered me on, for her
confidence in me. I thank her for dealing with the realities of life on my behalf so I can do what I
want to do in blissful ignorance. Her attitude, strength and character have been a huge reason for
my success. I thank my father, Soundarapandian Shanmugam and my mother, Subbulakshmi
Subramaniam for the innumerable sacrifices they have made, and for the anxiety and pain, they
have gone through to make it possible for me to complete this process. I thank them for their

viii

support, for their recognition of my goals, their love and care. For this, I dedicate this thesis to
them. To me, being their daughter is an honor higher than any degree could ever offer.
The most difficult job is to thank the people who are on your cell phone speed dial. One
such person is my friend, counselor and the voluntary chair of the “let Mangala graduate
committee” Kathleen Nemec. I cannot thank her enough for her trust, love and relentless support
that have been my principal strength through out my PhD. I thank her for the countless pep talk
lunches that pushed me to finish this process. I thank her, for her trust in me and for constantly
improving my confidence and character. I thank her, for taking me into her family and giving me
a home so far from home. I thank her, for all the times that she “mommies” me, for all the force
feeding and everything that she wont stop doing for me as long as I shall live….
Finally, my thanks to George Kyriazis, for everything, for being my best friend, for
making my reason stronger, for being the shoulder to cry on, for listening and preaching. I thank
him for catching me on my every downfall, above all seeing me for what I am and showing me
what I could become. I thank him for his friendship that I have come to count on more than my
own abilities. He being no farther than a phone call or the end of the hallway is why I have
survived this frustrating process. I cannot even begin to appreciate the chitchats, the Ecco
Domani, the coffee breaks, the arguments and the hard rock concerts. I am glad that “I owe you
without having to repay you” for I do not see how. I thank you for suffering this with me.
All these people and many more are the reason I stand here today. I could not have gone
through this process without them. For this, I thank them. Above all, I thank science for letting
me be a part of the truth. Thank you.

ix

TABLE OF CONTENTS
CHAPTER I Regulatory Role of KATP Channels in Synaptic Transmission and
Degeneration during Epileptogenesis ........................................................................1
Back Ground ............................................................................................................................... 1
Epilepsy................................................................................................................................... 1
Excitatory glutamate synaptic transmission and neuronal degeneration ................................ 2
Molecular basis of KATP channels........................................................................................... 5
KATP channel function in pancreatic β cells............................................................................ 7
Mitochondrial KATP channels................................................................................................ 10
KATP channels in glutamate mediated synaptic degeneration ............................................... 11
Hypothesis KATP channels regulate NMDA receptor function ................................................ 14
Materials and Methods.............................................................................................................. 16
Neuron culture ...................................................................................................................... 16
Stable Kir6.1 gene silencing and virus infection ................................................................. 16
RT-PCR analysis................................................................................................................... 18
Electron microscopy ............................................................................................................. 19
Kainate administration .......................................................................................................... 20
Immunoprecipitation............................................................................................................. 20
Electrophysiology ................................................................................................................. 21
Treatment of cortical neurons with glutamate receptor antagonists ..................................... 22
LDH release assay................................................................................................................. 23
Propidium iodide staining ..................................................................................................... 23
Results....................................................................................................................................... 24
The Kir6.1 and Kir6.2 proteins are common at excitatory synapses .................................... 24
Generation of the Kir6.1 stable gene silencing in the hippocampus of adult mice .............. 26
Silencing Kir6.1 gene increases the susceptibility of mice to KA-induced seizures............ 27
The null mutant mice lacking the SUR1 gene are vulnerable to KA-induced seizures........ 29

x

Enhanced glutamate release in neurons lacking the Kir6.1 channels ................................... 31
Enhanced glutamate release in neurons lacking the SUR1 subunits .................................... 33
Kainic acid induced cell death is higher in SUR1-/- mice ..................................................... 35
Conclusion ................................................................................................................................ 39
Discussion ................................................................................................................................. 40

CHAPTER II AMPA Receptor Subunit GluR2 Gates Injurious Signals in
Ischemic Stroke........................................................................................................42
Back Ground ............................................................................................................................. 42
Ischemic stroke ..................................................................................................................... 42
Glutamate toxicity in neuronal injury ................................................................................... 44
NMDA receptor channels in selective neuronal injury......................................................... 45
Expression of Ca2+-Permeable AMPA receptors in vulnerable CA1 pyramidal neurons .... 46
Transcriptional regulation of GluR2 expression in CA1 neurons ........................................ 48
Inhibition of Ca2+-permeable AMPA receptor channels protects vulnerable neurons from
forebrain ischemic insult....................................................................................................... 49
Hypothesis Ca2+ permeable AMPA channel expression is increased during transient
forebrain ischemia..................................................................................................................... 52
Materials and methods .............................................................................................................. 53
Transient forebrain ischemia................................................................................................. 53
Electrophysiology ................................................................................................................. 53
Detection of GluR2 protein levels ........................................................................................ 54
Results....................................................................................................................................... 55
The numbers of functional AMPA channels do not change during ischemia ...................... 55
GluR2 protein level is reduced by transient forebrain ischemia........................................... 57
Conclusion ................................................................................................................................ 58
Discussion ................................................................................................................................. 59

xi

REFERENCES.........................................................................................................62

xii

LIST OF FIGURES
Figure 1. Glutamate mediated excitotoxicity.................................................................................. 3
Figure 2. Schematic representation of the structural organization of KATP channels...................... 6
Figure 3. KATP channel activation is linked to the metabolic status of the cell............................... 8
Figure 4. Activation of KATP channels counteracts glutamate toxicity........................................ 15
Figure 5. Flowchart representing the construction of Kir 6.1 SiRNA in an Adeno virus
Associated helper virus. ................................................................................................................ 17
Figure 6. Expression patterns of KATP channels in the hippocampus. ......................................... 24
Figure 7. Bar graphs showing presence of Kir6.1 at the pre-synaptic terminal............................ 25
Figure 8. Inhibition of the Kir6.1 gene expression in the hippocampus....................................... 26
Figure 9. KSiRNA effectively downregulates Kir6.1 mRNA levels............................................ 27
Figure 10. The Kir6.1 is physically associated with SUR1 proteins. ........................................... 29
Figure 11. Inhibition of Kir6.1 gene expression enhances KA-induced glutamate release at CA3
synapses. ....................................................................................................................................... 32
Figure 12. Kainate increases glutamate release at CA3 synapses in the hippocampus. ............... 35
Figure 13. Neurons in mutant mice with KATP channel deficiencies are vulnerable to KA (LDH
release) .......................................................................................................................................... 36
Figure 14. Neurons in mutant mice with KATP channel deficiencies are vulnerable to KA (PI
staining)......................................................................................................................................... 38
Figure 15. Glutamate toxicity in ischemic injury. ........................................................................ 43
Figure 16. GluR2 gene is edited at the Q/R site ........................................................................... 46
Figure 17. Induction of Ca2+-permeable AMPA receptor channels primes cell death. ............... 51
Figure 18. Surface expression of GluR2 subunit is increased during ischemia........................... 52
xiii

Figure 19. The mean amplitude of miniature EPSCsAMPA remain unchanged in CA1 pyramidal
neurons following transient forebrain ischemia............................................................................ 56
Figure 20. GluR2 proteins in CA1 hippocampus is reduced following transient forebrain
ischemia. ....................................................................................................................................... 57

xiv

LIST OF TABLES
Table 1. Seizure severity and latency of onset after administration of kainate in Kir6.1 silenced
mice............................................................................................................................................... 28
Table 2. Seizure severity and latency of onset after administration of kainate in SUR1-/- mice. . 30

xv

CHAPTER I
REGULATORY ROLE OF KATP CHANNELS IN SYNAPTIC
TRANSMISSION AND DEGENERATION DURING EPILEPTOGENESIS

Back Ground
Epilepsy
Epilepsy is a neurological disease arising from severe seizure activity in the brain. It is a
high-risk disease affecting 24 to 53 people per 100000 individuals in developed countries

1, 2

.

About 70% of the cases are idiopathic, meaning they have no clear underlying cause. The rest of
the causes, range from genetic factors to head trauma or stroke. Some of the types of epilepsy
are childhood absence epilepsy, benign focal epilepsy, juvenile myoclonic epilepsy and temporal
lobe epilepsy (TLE) 3. TLE is the most common form of epilepsy in adults. It arises due to
seizure activity in the temporal lobes. It is further classified based on origin into Mesial TLE
arising from the hippocampus, amygdala or the para hippocampal gyrus and Lateral TLE arising
from the neocortex. Chronic TLE results in hippocampal sclerosis causing memory problems in
adults and learning disabilities in children. It commonly manifests in a status epilepticus state or
recurrent seizures, which might lead to brain damage. It is also very resistant to drugs and often
requires surgical intervention. Although extensive research has been done using animal models
to characterize this form of epilepsy, there are still huge gaps to be filled before an effective
strategy is formed to combat this disease 4-7.
Neuronal activity is a balance between the excitatory and inhibitory signals from the
presynaptic termini. Thus, the uncontrolled firing during epileptogenesis is a result of decreased

1

GABA release from the pre-synaptic terminals and hence decreased inhibition or increased
excitatory glutamate release leading to increased excitation and eventually excitotoxicity

8-11

.

Excitatory glutamate synaptic transmission and neuronal degeneration
Glutamate is the major excitatory transmitter in the mammalian central nervous system
(CNS) and plays an essential role in neural development, excitatory synaptic transmission, and
plasticity 12. On the other hand, glutamate mediated excitatory insults are implicated in a number
of acute neurological disorders including stroke

13, 14

and traumatic brain injury

15

as well as in

chronic neurological disorders such as multiple sclerosis, Huntington’s disease, Parkinson’s
disease and Alzheimer’s disease

16

. In case of energy deficits (i.e., reduction of intracellular

ATP concentration) however, glutamate accumulates in the synaptic cleft due to increased
glutamate release from pre-synaptic termini and decreased glutamate uptake by the astrocytes 17,
18

. This results in extensive stimulation of the glutamate receptors and is eventually toxic to the

neurons 12, 19.
Glutamate activates three classes of ionophore-linked postsynaptic receptors, including
N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
(AMPA) and kainate (KA) receptors

20, 21

. Activation and opening of these channels causes an

influx of cations and opening of Ca2+ channels 22. The subsequent influx of Ca2+ causes further
glutamate release and initiates the process of neuronal cell loss. This phenomenon has been
referred to as excitotoxicity (Figure 1) 23.
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Figure 1. Glutamate mediated excitotoxicity
a) Glutamate is released spontaneously from presynaptic termini. They activate postsynaptic receptors NMDA and AMPA. Activation of AMPA receptors makes them permeable to
sodium ions that depolarize the cell. Depolarization opens NMDA receptors that is permeable to
calcium in addition to sodium. This calcium along with the calcium from the VDCC leads to
further glutamate release. When the cell depolarizes, the potassium channels open and efflux
positively charged potassium ions that hyperpolarizes the neuron. This brings the neuron back to
the resting membrane potential. b) Increase in glutamate release from the pre-synaptic termini
allows repeated neuronal excitation that causes the entry of lethal levels of Ca2+ and leads to
glutamate excitotoxicity.
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The NMDA receptors are made of a NR1 subunit combined to a regulatory subunit
NR2A-D

24, 25

. They are a unique subtype of glutamate receptors since they are permeable to

Ca2+ flow and their activation requires neuronal depolarization 26. This Ca2+ along with the Ca2+
from the VDCC leads to an overload that triggers several downstream lethal reactions including
nitrosative stress, oxidative stress and mitochondrial dysfunction

16

. AMPA receptors are made

of GluR1-4 subunits. They are highly permeable to Na+ and K+ and are involved in excitotoxicity
mediated cell death 27. Most AMPA receptors in the brain consist of a GluR2 subunit that makes
them impermeable to Ca2+

28, 29

. However, GluR2-containing AMPA receptors are decreased

during ischemia by down regulation of GluR2 mRNA expression and GluR2 RNA editing,
leading to AMPA receptors permeable to Ca2+

30-32

. The KA receptors are made of the GluR5-7

and KA1-2 subunits. Like AMPA receptors, the KA receptors mediate slow neuronal injury 33. In
addition to ionophore-linked receptors, glutamate also activates metabotropic glutamate
receptors (mGluRs), a large family of G-protein coupled receptors that modulate excitatory
synaptic transmission through several signal transduction mechanisms

34, 35

. Recent advances in

the molecular biology, physiology and pharmacology of these receptors revealed their potential
role in a variety of central nervous system disorders such as epilepsy, pain, ischemia, and
neurodegenerative diseases 36-38.
Excitation and generation of action potentials in a neuron also depends on a diverse array
of ion-gated channels for Ca2+, Na+, and K+. The opening of the voltage gated K+ channels is a
major component that causes repolarization of the cell to the resting potential. This property
allows the neuron to curb calcium influx and thus decrease extensive glutamate release 39. Thus,
activation of certain type of endogenous ion channels that are able to attenuate neuronal
depolarization may produce neuronal protective effects. One such potential candidate is the
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Potassium ATP channels (KATP channels). A reduction of intracellular ATP levels because of
energy deficit activates KATP channels, thereby preventing membrane epolarization. Hence, the
activation of KATP channels would be able to protect neurons from metabolic stress such as
hypoxia and epilepsy.

Molecular basis of KATP channels
KATP channels are an octameric complex consisting of inwardly rectifying K+ channels
(Kir6.1 and Kir6.2) and regulatory sulfonylurea receptors (SUR1, SUR2A and SUR2B), which
are a member of the ATP-binding cassette (ABC) protein family (Figure 2), 40, 41. The Kir6.1 and
Kir6.2 share 70% amino acid identity and the monomers have a pore loop domain flanked by
two transmembrane segments (TM1 and TM2). The N and C-terminal domains are cytoplasmic
and bind to ATP. A linker that connects TM1 to TM2 makes the channel selectively permeable
to K+ ion flow

40, 42

. Both the pore-forming subunits and the regulatory SUR receptors have ER

retention motifs. In case of the Kir6.2 subunits, the ER retention motif is located at the Cterminal between TM1 and NBF-1 domain. When it associates with SUR1 the ER retention
motif is masked, leading to expression of functional Kir6.2/SUR1 channels on the cell surface 43,
44

.
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Figure 2. Schematic representation of the structural organization of KATP channels.
a) KATP channels have two subunits, Kir and SUR. The Kir is made of two
transmembrane domains TM1 and TM2 and a cytoplasmic domain with an inhibitory site for
ATP binding. The SUR is composed of three transmembrane domains TMD0, TMD1 and
TMD2. They are connected by the linker regions L0 and L1. The Nucleotide Binding domains
(NBD1 and NBD2) that bind to ATP are cytoplasmic. They constitute the Walker motifs A and
B. b) Heteromeric assembly of KATP channels where four Kir and four SUR subunits come
together to form a functional channel.

There are different types of functional KATP channels based on the different combination
of the Kir and SUR subunits in different cell types. The Kir6.2/SUR1 complex is the β-cell KATP
channels, which controls insulin secretion in response to changes of blood glucose concentration

6

45

. The cardiac muscle, KATP channels consist of the Kir6.2 subunits and SUR2A receptors

46

.

The Kir6.1/SUR2B complex forms the vascular KATP channels and play critical roles in
regulation of vascular tonus, especially in the coronary arteries

45

. In contrast to peripheral

tissues, neuronal KATP channels are less understood. To date, the only molecularly characterized
KATP channel components expressed in the brain regions, including the hypothalamus
forebrain cholinergic neurons

48

, and striatum

49

47

, basal

, are thought to be the Kir6.2 types. Although

pharmacological approaches suggest the presence of SUR1 receptors

50

, their functional

properties in the brain are yet to be fully characterized. Recently, we used electron microscopy
(EM) combined with gene targeting approaches to study neuronal type KATP channels. Our
results demonstrate that, as opposed to the Kir6.2 channels that are most likely to be at perisynaptic sites, in the hippocampus, functional Kir6.1 channels are predominantly located in the
“active zone” of the pre-synaptic terminals that controls glutamate release

51

. Consistent with

these data, activation of KATP channels by channel openers reduces the release of several
neurotransmitters, including excitatory glutamate

51

, dopamine

49, 52, 53

as well as inhibitory γ-

aminobutyric acid (GABA) 49, 54.

KATP channel function in pancreatic β cells
KATP channel activity is regulated by nucleotides 55, 56. Binding of intracellular MgATP to
either the SUR or Kir6.2 subunits activates and/or deactivates these channels 40, 57, 58. Opening of
the KATP channel is also modulated by Phosphatidylinositol bisphosphate (PIP2)
mutations of the Kir6.2 gene

55, 61, 62

59, 60

and by

. The physiological function of the KATP channel has been

extensively characterized in the pancreatic-β cell. These channels are involved in the first phase
of insulin secretion. At normal glucose levels, the KATP channel is active (open). The loss of K+
7

maintains the cell at a hyperpolarized state. Increased blood glucose levels and subsequent
metabolism increases intracellular ATP levels that inactivate (close) the channel (Figure 3).
Subsequent depolarization opens voltage gated Ca2+ channels

44

. Increase in intracellular Ca2+

concentrations triggers insulin release. As levels of glucose fall, the KATP channels in the
glucose-responsive neurons in the hypothalamus are activated and this stimulates the pancreatic
β-cells to secrete glucagon bringing glucose levels to normal
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Figure 3. KATP channel activation is linked to the metabolic status of the cell.
a)

In Pancreatic β-cells, increase in glucose, increases ATP levels. This keeps the

channels inactive, depolarizing the cell and causing insulin granule release. In the brain,
physiological ATP concentrations keep the channel inactive. b) However when the metabolism
of the cell is compromised, like during an ischemic or epileptic episode, the levels of
intracellular ATP drops and the KATP channels are activated. Their activation effluxes potassium
ions and hyperpolarizes the cell. The loss of membrane potential blocks lethal Ca2+ entry.

8

Accordingly, KATP channel mutations are associated with many glucose-metabolism
related disorders. Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI) or Congenital
Hyperinsulinism (CHI) is an inherited disorder due to mutations on the SUR1 or the Kir6.2 genes
64

. Permanent Neonatal Diabetes Mellitus (PNDM) is another disease, which is often associated

with mental retardation and epilepsy due to Kir6.2 mutations 65, 66. Mutations have been reported
on the SUR1 subunit as well. Some of these mutations prevent trafficking of the channel to the
plasma membrane and others prevent activation of the channel in response to elevated
intracellular MgADP

67, 68

. Invariably, all mutations on the KATP channels decrease insulin

secretion and cause improper glucose metabolism

69, 70

. SUR1 knockout mice also have

diminished insulin release capabilities and hypoglycemia. Essentially, all these mice exhibit a
diabetic phenotype 71.
Several pharmacological compounds that serve as KATP channel openers or KATP channel
blockers have been useful for characterizing the function of KATP channels

72

. Diazoxide,

cromakalim and pinacidil are major openers of the KATP channels 58. Importantly, diazoxide that
has been prevalently used to treat insulin release related disorders

73

and is widely used to

distinguish the SUR2A-containing KATP channels from the SUR2B; the SUR2B is sensitive
while SUR2A is insensitive to diazoxide

74

. Sulfonylureas including glibenclamide and

tolbutamide serve as KATP channels blockers and are clinically used for the treatment of diabetes
75

. In spite of the availability of these KATP channel blockers and openers, their lack of specificity

is a huge limitation to differentiate between different types of KATP channels 45.

9

Mitochondrial KATP channels
In addition to the KATP channels on the cell surface, mitochondria have been found to
have their own KATP channels (mitoKATP) on their inner membrane. Like the cell membrane KATP
channels, they are also inhibited by ATP 76. Activation of mitoKATP has shown to exert various
protective effects by reducing infarct size during ischemia, blocking cytochrome C release and
increasing association of the anti apoptotic Bcl2 protein to the mitochondria

77

. Their major

contribution is protection from cell death as shown in ischemic preconditioning during cerebral
and cardiac ischemia

78-80

. Diazoxide opens the mitoKATP channels and 5-hydroxydecanoate

blocks it making them widely used compounds to study these channels

72

. The subunit

composition of the mitoKATP is controversial because several groups have attempted to decipher
their composition but with conflicting results

81, 82

. This can be attributed to the use of different

antibodies raised against different epitopes and their lack of specificity. Research is also
hampered by the lack of specific pharmacological tools that would allow for the functional
characterization of mitoKATP and cell membrane KATP channels 72.
One direct effect of excitatory glutamate toxicity is mitochondrial dysfunction

83, 84

.

Increase in cytoplasmic Ca2+ through the activation of NMDA (N-methyl-D-aspartate) subtype
glutamate receptors results in Ca2+ flow into the mitochondria through the Na-Ca uniporter 85. As
the mitochondrial matrix is depolarized the mitochondrial oxidative phosphorylation is impaired,
leading to ATP depletion 86. The swelling of the mitochondria results in membrane rupture and
release of pro-apoptotic proteins

87, 88

. In addition to extra cellular Ca2+, mitochondrial stores

released Ca2+ is also responsible for the intracellular Ca2+ overloading and neuronal cell death 89,
90

. Recent studies have shown that activation of mitoKATP during ischemia reduced Ca2+

accumulation in the heart mitochondria

91

. Activation of mitoKATP by diazoxide has also been
10

linked to a hyperpolarization in the mitochondria and decreased Ca2+ influx

92, 93

. Given that

accumulation of Ca2+ in the mitochondria also induces reactive oxygen species (ROS)-related
neuronal death

94-96

, it is reasonable to speculate that neuronal protection can be achieved by

activation of mitoKATP channels during excitotoxic injury.

KATP channels in glutamate mediated synaptic degeneration
Anoxia-hypoxia depletes cellular oxygen levels and induces anoxic depolarization. This
opens several voltage-gated channels leading to a massive overload of Na+ and Ca2+ ions
disrupting cellular functions and eventually leading to cell death

97, 98

. Activating KATP channels

in this case will cause anoxic hyperpolarization and dampen the depolarization-induced
glutamate excitotoxicity protecting neuronal cells

99

. Several investigators have addressed this

issue. For instance, Protein Kinase G (PKG) activates KATP channels by phosphorylation of
serine threonine residues. This contributes to anoxic preconditioning (APC) and was shown to
reduce anoxia/reperfusion induced cardiac damage in rat hearts

100

. It has also been shown that

zinc protects from ischemic damage of the hippocampus by inhibiting glutamate release from
mossy fiber synaptosomes. This was observed when micro molar concentrations of zinc opened
KATP channels during anoxic-hypoglycemic episodes

101

.

Recent studies using the null mutant mice lacking the Kir6.2 gene (Kir6.2-/-) indicate that
the most Kir6.2-/- mice die, whereas all wild-type control mice survive from 15-min occlusion of
the middle cerebral artery occlusion (MCAO). Although poor survival of these Kir6.2-/- mice
could be due to the surgical procedures but not due to the brain damage [a very small infarction
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size (11.67 ± 1.28 mm3) was observed in these mice] 102, it is generally agreed that expression of
KATP channels protects against neuronal injury from ischemic insults 45, 99.
In addition to ischemic neuronal death, respiratory arrest can induce epileptic activity,
which coupled with increased metabolism of the available cerebral oxygen decreases cellular
ATP levels and lead to activation of KATP channels. Increased efflux of K+ ions mediated by
these activated channels causes neuronal hyperpolarization that suppresses the epileptic
responses
hypoxia

103, 104

105

. Indeed the Kir6.2-/- mice exhibit an increased susceptibility to seizures after

. This can be explained because of the inwardly rectifying nature of the Kir subunit.

The subunit helps in hyperpolarizing the membrane following a depolarization and helps control
excitability.

Conversely, over expression of SUR1 in mice makes them more resistant to

generation of seizures 106. The regulatory nature of the SUR1 subunits probably helps to keep the
channel in an active state and thus preventing epileptogenesis.
The Substantia Nigra pars Reticulata (SNr) is a major brain region that controls the
propagation of seizures. It also has the highest expression of KATP channels especially the
pancreatic β-cell type (Kir6.2/SUR1) 105. As the SNr neurons are the central gating system from
where seizures propagate, the KATP channels in the SNr will be the first line of defense against
the propagation of seizures caused by ATP depleted conditions such as hypoxia and
hypoglycemia. As expected, the firing rate of SNr neurons of Kir6.2-/- mice was 1.8 fold higher
compared to the wild type. This effect was reversed by tolbutamide, a sulfonylurea that inhibits
KATP channels

107

. It should be noted here that, the specificity of tolbutamide depends on the

availability of Mg2+ and KATP channel subunit composition

75, 108

. Previous studies showed that

hypoxic insults activate KATP channels and in turn suppress epileptic activity in the Substantia

12

Nigra neurons

105

. Thus, the ability of the KATP channels to sense the metabolic state of the cell

will help reverse the cell damage by reducing membrane excitability.
Kainic acid (KA) is a glutamate analog that serves as an agonist for AMPA/KA
receptors 9. Activation of these receptors leads to a series of intracellular events including Ca2+
influx, Reactive Oxygen Species (ROS) production, increased Nitric Oxide Synthase (NOS)
levels, membrane depolarization, mitochondrial dysfunction and apoptosis 19. KA-induced status
epilepticus causes delayed and specific neuronal death in the pyramidal neurons of the CA3 and
CA1 areas of the hippocampus neurons

9, 109

. This cell death is mainly by the excitation of

AMPA type glutamate receptors, which as noted earlier are impervious to Ca2+

28, 29

.

Nevertheless, it has been observed that there is a reduction in the GluR2 mRNA expression
preceding cell death. Down regulation of GluR2 mRNA facilitates AMPA mediated Ca2+ entry
into CA3 pyramidal neurons and causing neuronal death 19, 30, 31, 110. The epileptic activity in the
CA3 is also largely generated by the GluR6 receptors 111.
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Hypothesis
KATP channels regulate NMDA receptor function
Glutamate excitotoxicity is a major cause of neuronal cell death during ischemia and
seizures. Glutamate is released from pre-synaptic terminals and activates postsynaptic glutamate
receptors like NMDA, AMPA and KA

20, 21

. Over-stimulation of NMDA receptors due to

glutamate accumulation is lethal as these receptors are permeable to toxic Ca2+ ions

112

. Hence,

mechanisms that counteract this phenomenon play an essential part in neuronal protection. The
ability of the KATP channels to activate and hyperpolarize the cell in response to a drop in ATP
levels places them at a unique position to sense and modulate the activation of glutamate
receptors (particularly, NMDA receptors, a principle subtype of glutamate receptors, since they
are activated only if membrane potentials are depolarized). Accordingly, activation of KATP
channels will induce neuronal hyperpolarization, prevent NMDA receptor channel opening, and
hence protect from hypoxic/ischemic insults and epileptogenesis (Figure 4).
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Figure 4. Activation of KATP channels counteracts glutamate toxicity.
a) KATP channels are inactive. Hypoxic/ischemia depolarizes neuronal terminals and leads
Ca2+ influx through voltage-gated Ca2+ channels (VDCC). Ca2+ entry triggers glutamate release
that activates postsynaptic glutamate receptors including NMDA and AMPA receptors. Overstimulation of NMDA and AMPA receptors leads to Ca2+ overloading in the post-synaptic
neurons, resulting in neuronal death. b) KATP channels are activated. Hypoxic/ischemia also
activates KATP channels and in turn hyperpolarizes neuronal terminals. Neuronal hyperpolarization inactivates VDCC and in turn terminates Ca2+-dependent glutamate release, thereby
protecting against ischemic insults.
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Materials and Methods

Neuron culture
Cortical neurons were cultured from P1 pups. The brains were dissected onto HBSS. The
meninges were removed and the cortices were extracted. The tissue was digested with trypsin at
37°C for 15 minutes. The enzyme was inactivated with horse serum and spun at 1000rpm, 5
minutes at 22°C. The pellet was triturated 10 times with a fire polished Pasture pipette. The cell
suspension was spun at 1000rpm, 5 minutes at 22°C to pellet the neurons. The cells were
resuspended in Neurobasal medium supplemented with B27, 0.5mM Glutamax, PSN, 25µM
Glutamate and plated at a concentration of 1 X 105 per well. The neurons were then maintained
in feeding medium (Neurobasal medium supplemented with B27, 0.5mM Glutamax and PSN)
until treatment at 37°C, 5% CO2.

Stable Kir6.1 gene silencing and virus infection
Kir6.1 siRNA (KsiRNA) sequence (forward: 5′-GGUGAAUGGCCAGGUUUUUtt-3′;
reverse: 5′-AAAAACCUGGCCAUUCACCtc-3′) was provided by Ambion, Inc. (Austin, TX)
and synthesized as two cDNA oligonucleotides, which were cloned in pSilencer-U6 through
BbsI/BstB sites, as described before

31, 32, 113

. The U6-KsiRNA cassette was re-cloned into

rAVETM construct containing eGFP through ApaI/KpnI (GenDetect, New Zealand), creating a
vector rAVE-U6/KsiRNA-CAP/eGFP. A control vector was used to express a scrambled
KsiRNA (rAVE-U6/SKsiRNA-CAP/eGFP). The rAVE plasmids were co-transfected with the
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AAV helper 2 into HEK293 cells to generate the rAAV2 virus particles. The high titer infectious
virus particles were purified and calculated by GenDetect Inc. (New Zealand). The infectious
particles were then perfused (2 µl at 0.2 µl/min) into each side of the hippocampus (2.1 mm
posterior to bregma; 1.9 mm lateral to the midline; 2.6 mm below dura) of mice, as previously
described 31, 32, 113. 12 days after injection, the mice were subjected to experimentation.

5’-GGUCAUUCACGUCUGGAUUtt- 3’

pSilencer

U6

KSiRNA

rAVE-KSiRNA

U6

KSiRNA

CAP

eGFP

U6

SKSiRNA

CAP

eGFP

rAVE-SKSiRNA

AAV helper 2 virus

Hippocampal injection

Figure 5. Flowchart representing the construction of Kir 6.1 SiRNA in an Adeno virus
Associated helper virus.
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RT-PCR analysis
RNA was isolated from the hippocampus of mice without or with infection of the virus
particles and treated with the DNA-freeTM kit (Ambion), as described before 31. Sample aliquots
containing 25 µg RNA were incubated for 30 min at 37°C with 2 IU DNase I in DNase reaction
buffer [10 mM Tris–Cl (pH 7.5), 2.5 mM MgCl2, 0.1 mM CaCl2] in a total volume of 50 µl. The
reaction was stopped by addition of 5 µl resuspended DNase Inactivation Reagent and incubation
at room temperature for 2 min. This reagent, as well as the DNase I and divalent cations, were
removed by centrifugation at 10000xg for 1 min. DNase I-treated RNA samples were reversetranscribed in a 20 µl reaction volume containing 50 mM Tris–HCl (pH 8.3), 75 mM KCl, 3 mM
MgCl2, 10 mM dithiothreitol, 500 ng oligo(dT)15

primer and 200 IU M-MLV reverse

transcriptase (Promega, Madison, WI) for 1 hr at 42°C. Control samples, where no reverse
transcriptase was added, were included in all experiments to show that all products were RNAderived and not the result of genomic DNA contamination. PCR amplification was carried out
with 5 µl cDNA product in a 50 µl reaction volume containing 20 pmol of each specific
oligonucleotide primers: Kir6.1 nucleotides 277-615 (accession no. NM-008428) forward: 5’AAAGGAAGATGTTGGCCAGGAA-3’,

reverse: 5’-CCATGGTGCCTTTCTCCATGTA-3’,

50 nmol/l dNTP, 1.25 IU Taq DNA Polymerase (5 IU/µl) (Roche Diagnostics, Mannheim,
Germany) in 10 mM Tris–HCl, 1.5 mM MgCl2, 50 mM KCl (pH 8.3). After an initial pre-heat at
95°C, PCR amplification was carried out for 22 to 45 cycles of denaturation at 95°C (20 s),
annealing at 52°C (45 s), and extension at 72°C (1 min), followed by a final extension at 72°C
for 10 min. The number of cycles used was limited to ensure product amplification remained in
the log-linear range. ß-actin was adopted as a control. PCR products were separated by
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electrophoresis on a 1.5% agarose gel and visualized after ethidium bromide staining over UV
light.

Electron microscopy
The post-embedding immuno-gold method has been described

114, 115

. In this study,

sections from the CA1 stratum radiatum of the hippocampus of 3 male Sprague−Dawley rats (37
days old). Rats were perfused with 4% paraformaldehyde plus 0.5% glutaraldehyde in 0.12 M
phosphate buffer. Parasagittal sections (250 µm) of the hippocampus were cryoprotected in 30%
glycerol and frozen in liquid propane in a Leica EM CPC. Frozen sections were immersed in
1.5% uranyl acetate in methanol at −90°C in a Leica AFS freeze−substitution instrument,
infiltrated with Lowicryl HM-20 resin at −45°C, and polymerized with ultraviolet light. Thin
sections of the hippocampus were incubated in 0.1% sodium borohydride plus 50 mM glycine in
Tris−buffered saline/0.1% Triton X−100 (TBST), followed by 10% normal serum (NS) in TBST.
One set of the experiments were done using a 10-day old rat, anti-Kir6.1 (1:300) and anti-Kir6.2
(1:300) antibodies were provided by Dr Andrew Tinker (University College London, London,
UK). Another set of the experiments were done on three adult rats, using anti-rabbit Kir6.1
antibody (1:80) purchased from Sigma (P0874) and anti-goat Kir6.2 antibody (10 µg/ml)
purchased from Santa Cruz (SC-11226). The antibodies were prepared in 1% NS/TBST and
10nm immunogold was prepared in 1% NS/TBST plus 0.5% polyethylene glycol, and finally the
sections were stained with uranyl acetate and lead citrate. The anti-Kir6.1 antibody was raised in
rabbits against a peptide corresponding amino acids 399-RRNNSSLMVPKVQFMTPEGNQC420) and anti-Kir6.2 was raised in goats against Kir6.2 peptide corresponding amino acid 357-
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372. For quantification of random areas of the CA1 stratum radiatum from the 3 P37 rats, all
spine synapses with gold labeling within 20 nm of the cell membrane of the presynaptic terminal
and the postsynaptic spine were photographed and counted. The membrane was divided into 6
regions including the synaptic (=active zone), perisynaptic (=100 nm on either side of the active
zone), and extrasynaptic membrane of both the presynaptic terminal and the postsynaptic spine
membrane. A total of 56 synapses for Kir6.1 and 59 synapses for Kir6.2 were counted from the 3
animals. Statistical analysis used a two-tailed t-test.

Kainate administration
Adult male mice (90 ± 5 days old of age, 28 ± 2 mg body weight) were intraperitoneally
injected with kainic acid (30 mg/kg in PBS, A. G. Scientific Inc., San Diego, CA). Mice were
monitored continuously for 3 hrs. The severity of seizures was rated by the arbitrary scale: 1:
staring and immobility/wet dog shake; 2: hyperactivity, repetitive movements, rearing and
falling; 3: low seizures (intense shivering); 4: severe tonic/clonic convulsion; 5: death. The
averaged points for seizure severity in a given group were expressed as the seizure index.

Immunoprecipitation
Synaptosomes were generated as described before

31, 32, 113

. Briefly, the hippocampal

homogenate in 0.32 M sucrose was centrifuged for 10 min at 1,400g to yield a pellet (P1) and a
supernatant (S1). S1 was further centrifuged for 10 min at 13,800g, yielding a crude
synaptosomal pellet (P2) and a supernatant (S2). P2 was resuspended in 0.32 M sucrose
containing 1 mM NaHCO3 and layered on top of a discontinuous sucrose gradient (0.8, 1.0 and
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1.2 M). After centrifugation for 2 h at 82,500g, the synaptosomes were recovered as a band,
resuspended in 0.32 M sucrose and 1 mM NaHCO3 plus protease inhibitors, pelleted and
resuspended in HEPES buffer containing protease inhibitors.
Synaptosomes were incubated with 1% Triton X-100 for 20 min on ice and centrifuged at
14,000g for 15 mins to obtain the supernatant. Protein concentration in the extracts was
determined by Lowry assay (Bio-Rad). The extracts (~500µg protein) were incubated with
polyclonal rabbit anti-SUR1 (2 µg) overnight at 4°C, followed by the addition of 40 µl of Protein
G-Sepharose (Sigma) for 3 hr at 4°C. Immunoprecipitates were washed four times with PBS
buffer, denatured with SDS sample buffer, separated by SDS-PAGE and blotted with anti-Kir6.1
(Santa Cruz, 1:100), anti-SUR1, or anti-syntaxin-1A (Santa Cruz, 1:400) antibodies. Anti-SUR1
antibody was raised in a rabbit against the synthetic peptide CKRGAILEFDKPEKL (Sigma).
The antibody was purified by using an immunoaffinity column.

Electrophysiology
Hippocampal slices (250 µm) were prepared from mice, as described before

31, 32, 113

.

Slices in the recording chamber were continuously superfused with artificial cerebrospinal fluid
(ACSF, 2 ml/min) saturated with 95% O2/5% CO2 at 30°C ± 1°C. The composition of ACSF was
124 mM NaCl, 3 mM KCl, 1.25 mM NaH2PO4, 1.2 mM MgCl2, 2 mM CaCl2, 26 mM NaHCO3,
and 10 mM dextrose. For whole-cell patch-clamp recordings (tight seal >15-25 GΩ) from CA3
pyramidal cells, hippocampal slices were visualized with IR-DIC optics with an Axioskop 2FS
equipped with Hamamatsu C2400-07E optics. The spontaneous EPSCs were recorded at a
holding potential of -70 mV. The intracellular solution contained 142.5 mM Cs-gluconate, 7.5
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mM CsCl, 10 mM HEPES, 0.2 mM EGTA, 2 mM Mg-ATP, 0.3 mM guanosine triphosphate (pH
7.4; 296 mOsm). The currents were filtered at 5 kHz with a low-pass filter. Data were digitized
at a frequency of 10 kHz and stored online with the pclamp11 system (Axon Instruments, Inc.,
Foster, CA). The input resistance and series resistance in postsynaptic pyramidal cells were
monitored with prevoltage steps (−2 mV; 100 ms) at 5 min intervals throughout the period of the
experiment. Series resistance ranged from 11 to 17 MΩ. Input resistance was 346 ± 18 MΩ.

Treatment of cortical neurons with glutamate receptor antagonists
Primary cortical neurons on DIV14 were washed twice with Neurobasal medium and
treated with the following
i)

vehicle

ii)

400µM Kainic acid + 10µM MK-801 + 10µM CNQX

iii)

400µM Kainic acid

iv)

500µM glutamate + 10µM MK-801 and

v)

500µM glutamate

in Neurobasal for one hour. At the end of treatment the cells were washed 4X with complete
Neurobasal medium and let to recover in feeding medium (Neurobasal medium supplemented
with B27, 0.5mM Glutamax and PSN) for 5 hrs at 37°C, 5% CO2. The medium was recovered to
measure LDH release and the cells were stained with propidium iodide.

22

LDH release assay
The LDH release assay was carried out according to the manufacturer’s protocol
(Promega cytotox 96 Non-radioactive cytotoxicity assay kit). Briefly, 50µl of the medium was
mixed with 50µl of freshly reconstituted substrate in a 96 well plate. The plate was incubated in
the dark for 30 minutes at 22°C. The reaction was terminated with 50µl of stop solution and the
absorbance was read at 490nm. The average LDH release was calculated from 4 independent
experiments. The value was expressed as a percentage of LDH release normalized over
glutamate mediated cell death (treatment v) using the formula
% Cell death = [(absorbance treatment – absorbance control) X 100] / [absorbance
glutamate].

Propidium iodide staining
The cells were washed three times with Hanks Balanced Salt solution (HBSS) to remove
the culture medium. They were stained with Propidium iodide (PI) (3µM) in HBSS for 20
minutes at 37°C, 5% CO2 followed by 4X wash with HBSS. The stained cells were fixed with
4% para formaldehyde in PBS pH 7.4 at 22°C for one hour. The cover slips were then mounted
on glass slides using DPX Fluor mounting medium. The pictures were taken with a Carl Zeiss
Apotome microscope. The number of PI positive cells were counted manually and expressed as a
percentage of total cells in the field.
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Results

The Kir6.1 and Kir6.2 proteins are common at excitatory synapses
We first examined the expression of KATP channels in the hippocampus by immuno-gold
labeling of the Kir6.1 (Fig. 6a) and Kir6.2 (Fig. 6b) subunits. Overall, the labeling shows that
both Kir6.1 and Kir6.2 proteins are found on synaptic membranes of terminals and spines as well
as

in

vesicular

structures

within

the

synaptic

cytoplasm.

Figure 6. Expression patterns of KATP channels in the hippocampus.
Representative micrographs showing immunogold labeling of the Kir6.1 (a) and the
Kir6.2 (b) Proteins associated with synapses in the adult rat hippocampus. Arrows indicate the
labeling in the pre-synaptic (a) and pre-perisynaptic (b) membrane.
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By comparing the labeling patterns between Kir6.1 and Kir6.2 proteins, we found that the
Kir6.1 subunits were located predominantly in the presynaptic membrane (active zone), whereas
Kir6.2 subunit was most likely to be located in the perisynaptic area of the terminals (Fig. 7a and
7b). These findings indicate that Kir6.1 proteins in the presynaptic terminal are concentrated
within the synaptic active zone.

b)

a)

Kir6.2
Kir6.1

Figure 7. Bar graphs showing presence of Kir6.1 at the pre-synaptic terminal.

a) Bar graph summarizes the gold/synapse for the Kir6.1 (filled bars) and the Kir6.2
(open bars) labeling in pre-synaptic (pre-syn), pre-perisynaptic (pre-peri), pre-extrasynaptic (preextra), post-synaptic (post-syn), post-perisynaptic (post-peri) and post-extrasynaptic (post-extra)
membrane. Data are mean ± SEM (*p < 0.01). The left asterisk indicates the difference between
Kir6.1 pre-synaptic and pre-peri-synaptic (p < 0.01); and the right asterisk indicates the
difference between Kir6.2 and Kir6.1 pre-perisynaptic (p < 0.05). b) Bar graph shows a
percentage of total membrane gold for the Kir6.1 (filled bars) and the Kir6.2 (open bars). Data in
(a) and (b) are mean from three 37 days old mice.
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Generation of the Kir6.1 stable gene silencing in the hippocampus of adult mice
We next determined the potential functions of the synaptic KATP channels in the
hippocampus. We generated stable Kir6.1 gene silencing using small interfering RNA (siRNA)
that specifically targets to the Kir6.1 gene (KsiRNA). The KsiRNA was expressed in the
hippocampus

of

adult

mice

using

the

rAAV2-KsiRNA-eGFP

vectors

(Fig.

8)

Figure 8. Inhibition of the Kir6.1 gene expression in the hippocampus
The representative images of the hippocampus (left) expressing the KsiRNA and eGFP
were taken 12 days after injection of the infectious rAAV2-ksiRNA-eGFP virus particles. Higher
magnifications show the CA3 area of the hippocampus (middle) and pyramidal neurons (right).

Expression of a scrambled KsiRNA (SKsiRNA, rAAV2-SKsiRNA-eGFP vector) was
used as control. The Fluorescence images show that neurons expressing a reporter gene (eGFP)
were present throughout the hippocampus 12 days after infection with the rAAV2 virus particles.
A reduction of the Kir6.1 mRNA levels was detectable 6 days after infection with the rAAV2KsiRNA-eGFP, and the maximum inhibition of the Kir6.1 mRNA (Fig. 9a and b, 76.9 ± 5.3%, n
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= 6 assay/3 mice) was observed 6 days later (12 days after virus infection), demonstrating a
stable Kir6.1 gene silencing in the hippocampus of adult mice in vivo

a)

b)

Figure 9. KSiRNA effectively downregulates Kir6.1 mRNA levels
a) RT-PCR analysis shows the Kir6.1 mRNA in the hippocampus of mice 6 days or 12
days after without (control) or with infection of the rAAV2-sksiRNA-eGFP (lane 1) or the
rAAV2-ksiRNA-eGFP (lane 2) virus particles. b) Bar graph shows the Kir6.2 mRNA levels that
were normalized to β-actin in their respective conditions. Data are mean ± SEM (* p < 0.01).

Silencing Kir6.1 gene increases the susceptibility of mice to KA-induced seizures
Subsequently, we analyzed the susceptibility of adult mice with Kir6.1 gene silencing to
kainic acid (KA)-induced seizures, which are widely considered to be an animal model of human
temporal lobe epilepsy and are associated with hyper-excitation in some subsets of neurons in the
hippocampus 9. Mice were injected with KA (30 mg/kg, i.p.) 12 days after infection with the
rAAV2-KsiRNA-eGFP (KsiRNA mice) or the control rAAV2-SKsiRNA-eGFP (SKsiRNA
mice) virus particles. The latency and severity of seizures were then diagnosed and expressed as
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seizure index. Our data, as summarized in Table 1, show that all the KsiRNA mice suffered
severe seizures including hyperactivity, constant rearing and falling. 7 of 10 KsiRNA mice had
tonic convulsion and died within 3 hr (seizure index = 4.4 ± 0.31, n = 10). In contrast, the
majority of the SKsiRNA mice showed no hyperactive responses and remained alive throughout
the course of observation (seizure index = 2.56 ± 0.34, n =10).

Table 1. Seizure severity and latency of onset after administration of kainate in Kir6.1
silenced mice.

Experimental Groups

No. of mice dead

Seizure Index

Latency (min)

(% mortality)

(mean ± SEM)

(mean ± SEM)

SKsiRNA

2/10 (20%)

2.56 ± 0.34

30.1 ± 1.1

KsiRNA

7/10 (70%)

4.40 ± 0.31*

34.5 ± 3.7

The SKsiRNA and KsiRNA represent the mice that were intra-hippocampally injected
with the rAAV2-SKsiRNA-eGFP or the rAAV2-KsiRNA-eGFP virus particles, respectively.
The Kir6.1 silenced mice show increased susceptibility to kainic acid induced epileptogenesis
and exhibit higher mortality rates compared to the control, scrambled SiRNA injected mice. *p <
0.01, compared to controls.

To determine the functional partners of the Kir6.1 channels in the hippocampus, we
precipitated the Kir6.1 protein complex in synaptosomes. Western blot analysis demonstrated the
presence of the SUR1 proteins in the precipitates, indicating that the Kir6.1 subunits form a
complex with SUR1 receptors. In addition to SUR1, we also found Syntaxin 1A, one of the
SNARE proteins that participate in transmitter release, in the Kir6.1 protein complex (Fig. 10).
These results confirm the labeling of functional Kir6.1/SUR1 channels at pre-synaptic terminals.
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Co-IP
Input

NS-IgG

SUR1
−50
−37

Anti-kir6.1

−250
−150

Anti-SUR1

−37

Anti-syntaxin-1A

−25

Figure 10. The Kir6.1 is physically associated with SUR1 proteins.
Endogenous Kir6.1 and SUR1 proteins in synaptosomes from adult mouse hippocampus
were precipitated with nonspecific IgG or anti-SUR1, and blotted with anti-Kir6.1, anti-SUR1, or
anti-syntaxin-1A, as indicated. In the lane marked input, 50 µg of proteins without
immunoprecipitation was loaded. Similar results were observed in four independent experiments.

The null mutant mice lacking the SUR1 gene are vulnerable to KA-induced
seizures
Accordingly, we examined the seizure vulnerability of the null mutant mice lacking the
SUR1 gene (SUR1-/-). We found that 8 of 11 SUR1-/- mice revealed tonic and clonic convulsion
and died within 3 hr after seizure induction (seizure index = 4.73 ± 0.14), whereas most wildtype control (SUR1+/+) mice survived (seizure index = 1.73± 0.36, n = 11, Table 2) and did not
exhibit severe seizures. In addition to Kir6.1, the Kir6.2 subunits also form function channels
with SUR1 receptors in the pancreatic β-cells
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and possible in some subsets of neurons in the
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brain

47-49, 105

. We found, however, that the mutant mice lacking the Kir6.2 gene (Kir6.2-/-,

seizure index = 2.56 ± 0.34, n =12, Table 1) did not show a difference in the latency and severity
of seizures compared with that of wild-type control (Kir6.2+/+) mice (seizure index = 1.73 ± 0.36,
p > 0.01, n = 11, Table 2). Together, these results demonstrate a crucial inhibitory role of the
Kir6.1/SUR1, but not of the Kir6.2 channels, in generation of hippocampus-dependent epileptic
form of seizures.
Table 2. Seizure severity and latency of onset after administration of kainate in SUR1-/mice.

Experimental Groups

No. of mice dead

Seizure Index

Latency (min)

(% mortality)

(mean ± SEM)

(mean ± SEM)

Controls

1/11 (9.1%)

1.73 ± 0.36

SUR1-/-

8/11 (73%)

4.73 ± 0.14*

32.3 ± 2.0

Kir6.2-/-

2/12 (16%)

2.50 ± 0.34

38.1 ± 1.7

a

N/A

Controls are wild-type C57BL/6 mice. The SUR1-/- mice show increased susceptibility to
kainic acid induced epileptogenesis and exhibit higher mortality rates compared to wild type
controls as well as the Kir6.2-/- mice. aData are not available since only one mouse in this group
suffered seizures within 3 hrs after treatment of KA. *p < 0.01, compared to controls.
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Enhanced glutamate release in neurons lacking the Kir6.1 channels
Generation of epileptic form of seizures largely results from release of excitatory
glutamate transmitter at CA3 synapses in the hippocampus 9. Given that the Kir6.1 proteins are
found to be located at pre-synaptic terminals, we hypothesized that the neurons lacking the
Kir6.1 channels may have enhanced release of glutamate transmitter for the induction of
seizures. To test this hypothesis directly, we recorded the spontaneous excitatory postsynaptic
currents (sEPSCs) from CA3 pyramidal neurons in the hippocampus of the KsiRNA (Fig. 11a)
and the KSsiRNA mice (Fig 11b). The frequency of the sEPSCs onsets during KA application in
the KsiRNA mice (2.12 ± 0.23 Hz, mean ± SEM, n = 12/recordings/4 mice Fig. 11c) were
increased, compared to the KSsiRNA mice (1.23 ± 0.21 Hz, mean ± SEM, n = 12/recordings/4
mice). The mean amplitudes were statistically identical between groups (Fig. 11d).
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Figure 11. Inhibition of Kir6.1 gene expression enhances KA-induced glutamate release at
CA3 synapses.
(a-d) The traces are representatives of the spontaneous EPSCsAMPA recorded at holding
potential of -70 mV from CA3 pyramidal neurons in the hippocampus expressing scrambled
siRNA (SsiRNA, a) or the Kir6.1 siRNA (KsiRNA, b). Horizontal bar above the traces indicates
kainate application. Bar graphs summarize the frequency (c) of the EPSCsAMPA onset and the
mean amplitudes of the EPSCsAMPA (d). Data are mean ± SEM (n = 12 recordings/4 mice/group,
*P < 0.01).
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Enhanced glutamate release in neurons lacking the SUR1 subunits
Following our data the SUR1 seems to be the regulatory component of the Kir6.1
containing KATP channels in the hippocampus. Therefore, we hypothesized that their absence
might also increase glutamate release from pre synaptic terminals. Therefore, we recorded the
sEPSCs in CA3 pyramidal neurons from the SUR1-/- and the Kir6.2-/- mice (Fig. 12a). In this line
of the experiments, the sEPSCs variability was estimated. The distribution of the sEPSCs at the
baseline had clearly distinguishable peaks, and was fitted by the sum of multiple Gaussian
functions (Fig. 12a). The frequency of sEPSCs was increased following application of KA,
whereas the mean amplitude was unchanged (Fig. 12c). By comparison of the recordings
between CA3 pyramidal neurons from the SUR1-/- and wild-type control mice, our results
indicate that genetic deletion of SUR1/Kir6.1 channels increases glutamate transmitter release at
CA3 synapses.
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Figure 12. Kainate increases glutamate release at CA3 synapses in the hippocampus.
(a) Representative traces are from whole-cell patch clamp recordings of spontaneous
EPSCs at holding potentials of -70 mV from CA3 pyramidal neurons in the hippocampus from
wild-type controls (n = 14 cells/10 mice), or the Kir6.2-/- (n = 12 cells/7 mice) or the SUR1-/- (n =
15 cells/7 mice) mice. Averaged spontaneous EPSCs before and during KA are shown in the
right. Horizontal bar above the traces indicates kainate application. Note that kainate produced
depolarizing currents (arrows) in the CA3 pyramidal neurons, but the mean amplitudes of the
currents were no difference among groups. (b) Amplitude distribution histograms for the
spontaneous EPSCs before (top) and during (bottom) KA are plotted with bin sizes of 4 pA. (c)
The frequency but not the mean amplitude is increased at CA3 synapses in the hippocampus
from the SUR1-/- mice. Data are mean ± SEM (* p < 0.01).

Kainic acid induced cell death is higher in SUR1-/- mice
Our observations along with others have shown that although C57BL/6 mice undergo
epileptic seizures on treatment with kainic acid, they do not show any neuronal cell death in vivo.
To test this effect in vitro we treated primary cortical neurons from wild type controls, SUR1-/and Kir6.2-/- mice with kainic acid (Figure 13). The cell death in these neurons was measured in
terms of the LDH released. The KATP channel deficient neurons treated with kainic acid showed
increased susceptibility to cell death as compared to wild type controls. This susceptibility was
completely abolished in all genotypes when the glutamate receptor activation was blocked with
specific blockers MK-801 (NMDA) and CNQX (AMPA). This shows that the kainic acid
mediated excitotoxicity is mediated by glutamate activating postsynaptic glutamate receptors. It
also shows that this excitotoxicity can be effectively counteracted by functional KATP channels.
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Figure 13. Neurons in mutant mice with KATP channel deficiencies are vulnerable to KA
(LDH release)
Cortical neuron cultures (DIV14) from wild type, Kir6.2-/-, and SUR1-/- mice were
exposed to 400 µM kainic acid (KA) for one hour. Neuronal cell death was calculated by
measuring the efflux of LDH 6 hrs later. Data is expressed as % LDH release by KA normalized
to 500µM glutamate treatment (defined as 100%). Cultures from SUR-/- mice show increased
neuronal cell death compared to wild type cultures (*p < 0.005, n = 4). This data is in
concordance with the observations that absence of functional KATP channels increases glutamate
receptor mediated excitotoxicity.

We observed similar results when kainic acid treated neurons were stained with
Propidium Iodide (PI) (Figure 14). The SUR1-/- and Kir6.2-/- neurons showed increased PI
staining compared to the wild type controls.
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Figure 14. Neurons in mutant mice with KATP channel deficiencies are vulnerable to KA (PI
staining)
Cortical neuron cultures (DIV14) from wild type, Kir6.1-/-, and SUR1-/- mice were
exposed to 400 µM kainic acid (KA) for one hour. a) Representative pictures of PI staining to
show increased staining in SUR1-/- cultures compared to wild type controls. b) Neuronal cell
death was quantified by counting PI positive cells. Data is expressed as percentage of PI positive
cells over total number of cells. Cultures from SUR-/- and Kir6.2-/- mice show increased neuronal
cell death compared to wild type cultures (*p < 0.005, n = 4).
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Conclusion
¾

This study has identified for the first time the presence of Kir6.1 subunit in the active
zone of the pre-synaptic terminal.

¾

This study also places Kir6.1/SUR1 type KATP channels and Syntaxin 1A in the same
complex demonstrating their function in glutamate vesicle release.

¾

This data also means that Kir6.1 and SUR1 constitute the functional KATP channels in the
active zone.

¾

Accordingly, Kir6.1/SUR1 type KATP channels in the hippocampus can block glutamate
release thus curbing epileptogenesis.

¾

Finally, the results show that KATP channel deficient mice are more prone to neuronal cell
death due to their inability to block glutamate-mediated excitotoxicity.
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Discussion
To date, the only molecularly characterized KATP channel components expressed in the
brain regions including the hypothalamus 47, basal forebrain cholinergic neurons 48, and striatum
49

, is the Kir6.2 subunits, which are thought to protect against hypoxic insults. Although

pharmacological approaches suggest the presence of SUR1 receptors

116

, their functional

properties in the brain have yet to be fully characterized. In the present study, we used electron
microscopy combined with gene targeting studies. Our results clearly demonstrate that, as
opposed to the Kir6.2-containing channels, functional KATP channels at pre-synaptic terminals in
the hippocampus are formed by Kir6.1 subunits and SUR1 receptors. Mice with deficiencies in
expression of either the SUR1 gene or the Kir6.1 gene are vulnerable to KA-induced seizures, an
animal model of human temporal lobe epilepsy 9. Thus, expression of functional Kir6.1/SUR1
channels can be considered as an endogenous cellular protective event against epileptic activity.
Behaviorally observable seizures are induced by sustained, paroxysmal neuronal network
activity due to the spreading of uncontrolled excessive glutamate synaptic transmission in the
hippocampus 9. Consistent with this, our data show that release probability of glutamate at CA3
synapses lacking the Kir6.1/SUR1 channels, but not the Kir6.2-containing channels, is increased
during induction of epileptic form of seizures. Hence, expression of functional Kir6.1/SUR1
channels is able to attenuate the danger of over-stimulation of glutamate transmission for
generation of epileptic form of seizures.
The release of glutamate by pre-synaptic terminals is the initial event in generation of
epileptic activity. The link between KA receptor activation and glutamate release is vague. Rise
in intracellular Ca2+ concentration is a trigger for secretion as seen in insulin granules in the
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pancreatic β-cells

63

and glutamate vesicle release in neuronal cells

117

. In the presence of

glucose, high concentrations of ATP inhibit the KATP channels. This depolarizes β-cell
membranes opening voltage-gated Ca2+ channels (VDCC)

44

. In pancreatic β-cells, Epac2, a

cAMP dependent Guanine exchange factor interacts with the NB-1 domain of the SUR1 subunit.
This interaction inhibits the KATP channel and increases insulin secretion.
Similar to insulin secretion from β cells, glutamate release from pre-synaptic terminals is
triggered by Ca2+ influx through VDCC, which is known to be regulated by Epac2 protein
complex including Rim2 and Piccolo. Piccolo in addition can bind to the SUR1 receptors 118-120.
It has been known that activation of KA receptors elevates cAMP levels

121 122, 123

;

. Thus,

application of KA may activate cAMP-dependent Epac2 in the Piccolo/SUR1/Kir6.1 channel
complex and in turn regulate Ca2+-dependent glutamate release.
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CHAPTER II
AMPA RECEPTOR SUBUNIT GLUR2 GATES INJURIOUS
SIGNALS IN ISCHEMIC STROKE
Back Ground
Ischemic stroke
Ischemic stroke is caused by occlusion of blood vessels supplying the brain and is the
third leading cause of death in developed countries. A critical feature of brain injury following
transient forebrain ischemic insult is a highly selective pattern of neuronal loss in the central
nervous system (CNS). Certain identifiable subsets of neurons are severely damaged, including
CA1 pyramidal neurons in the hippocampus, cortical projection neurons in layer 3, and medium
spiny neurons in the dorsolateral striatum, whereas other neurons in the brain remain intact 32, 113,
124

. One step in this selective neuronal injury involves excessive stimulation of glutamate

receptor (GluR) channels, allowing inflow of massive amounts of Ca2+, Zn2+, and Na+ in
vulnerable neurons

125

. Ca2+ overload can trigger several downstream lethal reactions, including

nitrosative stress 126-130, oxidative stress 131, 132, and mitochondrial dysfunction133-136, as reviewed
earlier125,

137

and represented in figure 15. The over stimulation of GluRs is the primary

intracellular event that induces neuronal death. Therefore, synaptic GluR channels have been
considered a promising target for stroke therapy 138.
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Figure 15. Glutamate toxicity in ischemic injury.
CA1 pyramidal neurons degenerate 3 to 6 days after transient forebrain ischemia. The
cellular events underlying this delayed neuronal injury involve three phases. Phase I: during an
episode (approx 5 min) of forebrain ischemia, extracellular glutamate concentration in CA1 area
of the hippocampus increases because of increased vesicle release or decreased re-uptake by the
glutamate transporters. Ten minutes after ischemia, glutamate returns to the basal levels. Phase
II: occurs 6 to 12 h after ischemia. A critical feature in this phase is the sustained changes of
glutamate receptor channel activity, including: AMPA receptor channels become permeable to
Ca2+ and NMDA receptor channel activity is enhanced. Subsequently, sustained Ca2+ inflow
leads to mitochondria dysfunction and production of reactive oxygen species (ROS) and reactive
nitrogen species (RNS). Phase III: about 48 h after ischemia, ultimately, the neuronal cell is
damaged.
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Glutamate toxicity in neuronal injury
Glutamate plays an essential role in neural development, excitatory synaptic
transmission, and plasticity

24, 139-143

. Immediately following ischemia, however, glutamate

accumulates at synapses

144-146

eventually be neurotoxic

125, 137, 147, 148

, resulting in extensive stimulation of its receptors, which can
. Glutamate activates three classes of ionophore-linked

postsynaptic receptors—namely, NMDA, AMPA and kainic acid receptors. NMDA receptor
toxicity is dependent on extracellular Ca2+ and therefore, may reflect a large amount of Ca2+
influx directly through the receptor-gated ion channels

125, 137, 147-150

. Because most AMPA

receptor channels have poor Ca2+ permeability (with exceptions, as discussed later), injury may
result primarily from indirect Ca2+ entry through Ca2+-permeable transient receptor potential
channel member (TRPM)-7 channels127, Ca2+- permeable acid-sensing ion channels
voltage-gated Ca2+ channels

152

151

, and

. Although excess stimulation of GluRs contributes to ischemic

brain injury, blocking them completely could be deleterious to animals and humans because
targeting these receptors would also block the physiological action of glutamate in noninjured
neurons. Therefore, it may be fruitful to develop a practical approach whereby the pathological
effects of glutamate in vulnerable neurons is selectively blocked, leaving the physiological action
of glutamate in the CNS unaffected.
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NMDA receptor channels in selective neuronal injury
Glutamate toxicity largely results from NMDA receptor stimulation 125, 126, 137, 147, 148, 153.
Knockout mice lacking the NMDA receptor NR2A gene show decreased cortical infarction after
focal cerebral ischemia

154

. Systemic administration of an NMDA receptor antagonist protects

CA1 pyramidal neurons from ischemic injury

143

, suggesting that activation of NMDA receptor

channels following ischemia may mediate selective neuronal injury. However, these channels are
widely expressed in many types of neurons, including ischemia-sensitive and -insensitive
neurons in the CNS

155, 156

. Therefore, certain pathological signaling molecules that modulate

NMDA receptor function in vulnerable CA1 neurons may contribute to selective neuronal loss in
the hippocampus of rats following transient forebrain ischemia 113. NMDA receptor channels are
heteromeric complexes consisting of an essential NR1 subunit and one or more regulatory NR2
subunits, NR2A-D

24, 155, 156

. It was recently discovered that transient forebrain ischemia causes

phosphorylation of NR2A at serine-1232 (phospho- Ser1232) in rat CA1 neurons in vivo

113

. It

was also determined that cyclin-dependent kinase 5 (Cdk5) catalyzes Ser1232 phosphorylation
and that expression of a C-terminal peptide fragment of NR2A inhibits endogenous Cdk5 (or
perturbs the Cdk5-NR2A interaction), thereby abolishing Ser1232 phosphorylation and
protecting CA1 pyramidal neurons from ischemic insult

113

. In addition, Cdk5-mediated

regulation of NMDA receptor channels occurs only in CA1 neurons and not in other areas of the
hippocampus. This shows that the covalent modification of NMDA receptors by Cdk5 is an
essential intracellular event that determines vulnerability of neurons to the insult

113

. Therefore,

endogenous Cdk5 can be considered a suitable target regarding modification of cell survival
during disease.
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Expression of Ca2+-Permeable AMPA receptors in vulnerable CA1 pyramidal
neurons
Activation of endogenous Cdk5 depends on Ca2+ entry through AMPA receptors

113

,

which constitute a major GluR subtype 139, 141, 142, 144, 146. Functional AMPA receptor channels are
assembled from GluR subunits 1 through 4

139, 141, 142, 144, 146

. The Ca2+ permeability of AMPA

receptor channels is determined by the GluR2 subunit 28, 29, 157-162. In the adult CNS, nearly 100%
of the messenger RNA (mRNA) encoding GluR2 is edited at the Q/R site corresponding to
residue 607, where the genomic glutamine (Q607) codon is converted to an arginine (R) codon
(Figure 16) 28, 157-159, 161, 162. Edited GluR2(R) subunits form Ca2+-impermeable channels, whereas
unedited GluR2(Q) channels allow Ca2+ entry 28, 29, 157-162 (Figure 16).

Genomic Codon-607 (CAG)

N

M1

M2

M3

M4

C

RNA editing

mRNA Codon-607 (CIG)

N

M1

M2

M3

M4

C

••SLGAFMRQG••

••SLGAFMQQG••
Ischemia

N

M1

M2

••SLGAFMQQG••

M3

M4

C

RNA Editing

N

M1

M2

M3

M4

C

••SLGAFMQQG••

Figure 16. GluR2 gene is edited at the Q/R site
GluR2 gene is edited at the genomic glutamine codon (Q607). This changes the
aminoacid to an arginine forming Ca2+ impermeable GluR2(R) AMPA channels. During
ischemia, this RNA editing is disrupted causing increased expression of GluR2(Q) AMPA
channels that are permeable to Ca2+. This Ca2+ leads to excitotoxicity and cell death.
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In most CA1 neurons, AMPA receptor channels contain the GluR2(R) subunits and,
therefore, are impermeable to Ca2+ entry

29

. A recent study showed that transient forebrain

ischemia reduces GluR2 mRNA levels in hippocampal CA1 neurons 110. This observation led to
the “GluR2 hypothesis,” which postulates that reduced GluR2 expression allows Ca2+ entry
through AMPA receptor channels, which, in turn, induces CA1 pyramidal cell death

110, 163-165

.

The GluR2 hypothesis was proposed based on a causal relationship between CA1 pyramidal cell
injury and reduced GluR2 gene expression following transient forebrain ischemia

164, 165

.

Therefore, it is important to understand whether a decrease of GluR2 mRNA actually causes
AMPA receptor channels in vulnerable CA1 pramidal neurons to become permeable to Ca2+
entry. Ca2+ indicator dyes can be used to estimate AMPA receptor-mediated Ca2+ transients in
CA1 pyramidal neurons. Indeed, an earlier work demonstrated that AMPA caused a large rise of
intracellular Ca2+ in postischemic neurons compared to nonischemic control neurons

164

. Recent

studies involving whole-cell patch clamp recordings in individual CA1 pyramidal neurons from
the rat hippocampus (visualized with infrared illumination and differential interference contrast
(DIC, infrared- DIC) optics systems)

113 32

showed that AMPA receptors containing GluR2(R)

exhibit inward currents with high extra cellular Na+, but not high Ca2+. In contrast receptors
lacking GluR2(R) showed large inward currents with either high Na+ or Ca2+

32

. These data

allowed for the determination of the permeability of AMPA receptor channels to Ca2+ (PCa/PNa)
by calculating the shift in reversal potentials of AMPA receptor-mediated excitatory postsynaptic
currents (EPSCsAMPA) when the extra cellular solution was switched from high Na+ to high Ca2+.
Using this electrophysiological approach, it was also estimated that the Ca2+ permeability of
AMPA receptor channels in CA1 pyramidal neurons of rats 12 h after transient global ischemia
was 18-fold greater than that in sham controls. These data demonstrate that transient forebrain

47

ischemia induces AMPA receptor channels permeable to Ca2+ entry into vulnerable CA1
pyramidal cells.

Transcriptional regulation of GluR2 expression in CA1 neurons
Cell-survival-related gene expression has its basis in signaling cascades initiated by the
transcription factor Cyclic adenine monophospate Response Element Binding protein (CREB)
166-169

, which is believed to regulate GluR2 promoter activity

170

. Therefore, CREB activation

must stimulate the expression of the GluR2 gene and in turn, inhibit GluR2- gated injurious
signals in vulnerable CA1 neurons 32. Accordingly, when a constitutively active CREB, VP16CREB, was expressed in the rat CA1 pyramidal neurons in vivo

32

it inhibited Ca2+-permeable

AMPA receptor channels in vulnerable CA1 pyramidal neurons following transient forebrain
ischemia. Although the exact nature of the CREB signals for neuronal survival remains to be
determined, expression of GluR2(R) may be one of the CREB pathways responsible for neuronal
survival, because the protective role of CREB is abolished by directly introducing unedited
GluR2(Q) gene

32

. Therefore, on one hand, CREB increases GluR2 gene expression, thereby

increasing the relative level of GluR2(R). The finding that CREB induces expression of brainderived neurotrophic factor (BDNF) supports this hypothesis

171, 172

. BDNF binds to the GluR2

promoter that contains the gene silencing transcription factor neuronal repressor element-1
silencing transcription factor (REST)/neuron-restrictive silencer element (NRSE). Additionally,
it was reported that forebrain ischemia induces expression of REST and, in turn, reduces GluR2
gene expression

173

. Importantly, acute knockdown of the REST gene rescues postischemic

neurons from ischemia-induced cell death 173. Therefore, BDNF probably disrupts the interaction
48

of REST/NRSE with the GluR2 promoter, thus stimulating GluR2 gene expression

170

. On the

other hand, CREB activation may directly facilitate Q/R site editing of GluR2 mRNA, because
increased mRNA editing also increases GluR2 mRNA levels by reducing nuclear accumulation
of incompletely processed primary transcripts 174.

Inhibition of Ca2+-permeable AMPA receptor channels protects vulnerable
neurons from forebrain ischemic insult
Transient forebrain ischemia induces expression of Ca2+-permeable AMPA receptor
channels in vulnerable CA1 neurons, which then activates a series of intracellular injurious
signals 113. To investigate this possibility, it is necessary to selectively block Ca2+ permeability of
AMPA receptor channels in rat CA1 vulnerable neurons in vivo. An early work reported that
administration of Naspm, an open-channel blocker selective for Ca2+-permeable AMPA receptor
175, 176

, reduced GluR2 antisense-induced cell death and suggested that cell death induced by

multiple injections of GluR2 antisense was mediated by Ca2+-permeable AMPA receptors

163

.

Recently, virus-based gene expression vectors was used to introduce the GluR2(R) gene that is
independent of Q/R site editing into the adult rat hippocampus in vivo. Using whole-cell patch
clamp recordings, Liu S et al., obtained direct evidence that introduction of the GluR2(R) gene
selectively inhibits Ca2+ permeability of AMPA receptor channels occurring in vulnerable CA1
pyramidal neurons of adult rats following transient forebrain ischemia 32. This study provides the
first direct evidence that selective inhibition of Ca2+ permeability of AMPA receptor channels
rescues CA1 pyramidal neurons from forebrain ischemic insult 32.
In contrast to CA1 pyramidal neurons, granule neurons in the hippocampus are
insensitive to ischemic injury

32, 113, 124

, and AMPA receptor channels in these cells are Ca2+49

impermeable. To further demonstrate whether expression of Ca2+-permeable AMPA receptor
channels determine vulnerability of neurons to the insult, the granule cells were engineered to
express Ca2+-permeable GluR2(Q) channels by direct introduction of exogenous unedited
GluR2(Q) gene into the adult hippocampus. Following this manipulation, it was found that the
granule neurons degenerate following transient global ischemia

32

. Similarly to these results

observed upon expression of unedited GluR2(Q) gene, a recent report showed that delivery of
GluR2(Q) complementary DNA into the hippocampus by a liposome-mediated gene transfer
increases the sensitivity of neurons in the hippocampus to forebrain ischemia insult 177. Together,
it is suggested that the expression of Ca2+-permeable AMPA receptor channels provides a route
for toxic Ca2+ entry, which then triggers neuronal cell death in the hippocampus

178-182

. Ca2+-

permeable AMPA receptor channels are not only permeable to Ca2+ but are also highly
permeable to Zn2+
vulnerable neurons

178-182

and that a brief ischemic insult in rats induces Zn2+ accumulation in

183, 184

. Therefore, Ca2+/Zn2+ influx can be considered an initial event for

activation of an array of downstream enzymes that degrade membranes and proteins essential for
cellular integrity, as illustrated in Fig. 15. Thus, recent results demonstrate that expression of the
GluR2(R) gene blocks Ca2+ entry through AMPA receptor channels and prevents activation of
endogenous Cdk5 in vulnerable CA1 neurons

32, 113

. Furthermore, Cdk5 activation causes the

sustained opening of NMDA receptor channels, resulting in an intracellular Ca2+ overload. Taken
together these date leads to a model where GluR2-gated intracellular signaling cascade
determines selective neuronal vulnerability after forebrain ischemia, as described in Fig. 17.
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Figure 17. Induction of Ca2+-permeable AMPA receptor channels primes cell death.
AMPA receptor channels in CA1 pyramidal neurons normally contain an edited form of
GluR2 subunit (GluR2[R]) and, therefore, are Ca2+ impermeable. Following transient forebrain
ischemia, GluR2(R) levels in CA1 neurons decreases, resulting in Ca2+ entry through AMPA
receptor channels. The subsequent p25 accumulation leads to prolonged activation of Cdk5,
which phosphorylates the NR2A subunit of NMDA receptors at Ser1232 and induces further
Ca2+ entry through NMDA receptor channels, leading to cell death.

51

Hypothesis
Ca permeable AMPA channel expression is increased during
transient forebrain ischemia
2+

Delivery of GluR2 proteins from intracellular pools to the cell surface is required for
expression of functional AMPA receptor channels at CA1 synapses184, 185 as illustrated in Fig.
18.. So here we hypothesize that reduced GluR2 expression during an ischemic insult will reduce
the expression of functional AMPA channels on the cell surface. To test this hypothesis, we
performed electrophysiological analysis on CA1 synapses during an ischemic insult. We also
compared the expression of GluR2 protein levels between ischemic and physiological conditions.

GluR1

GluR2

GluR3

Figure 18. Surface expression of GluR2 subunit is increased during ischemia
The illustration shows GluR2-dependent translocation of GluR1/GluR2 receptor channels
at CA1 synapses. GluR1 is unable to incorporate into cell surface without GluR2.
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Materials and methods
Transient forebrain ischemia
Transient forebrain ischemia was induced in rats as described before 31. Briefly, 80 ± 5day-old Sprague Dawley rats were used. The bilateral vertebral arteries were exposed,
coagulated and cut completely 12 hr before the induction of ischemia. Ischemia was induced by
bilaterally occluding the common carotid arteries with aneurysm clips for 15 mins, after which
the clips were removed to restore cerebral blood flow. Body temperature was maintained at 37ºC
with heating pads until the animals had recovered from surgery. Sham-operated animals were
treated identically, except that the carotid arteries were not occluded. The brain was extracted
from these animals 12h later and processed for electrophysiology recordings or protein extraction
for immunoblotting analysis.

Electrophysiology
Sample traces of miniature EPSCsAMPA taken from CA1 pyramidal neurons in
hippocampal slices from rats 12 h after sham or transient forebrain ischemia. Hippocampal slices
(250 µm) were prepared from mice, as described before 31, 32, 113. Slices in the recording chamber
were continuously perfused with artificial cerebrospinal fluid (ACSF, 2 ml/min) saturated with
95% O2/5% CO2 at 30°C ± 1°C. The composition of ACSF was 124 mM NaCl, 3 mM KCl, 1.25
mM NaH2PO4, 1.2 mM MgCl2, 2 mM CaCl2, 26 mM NaHCO3, and 10 mM dextrose. For wholecell patch-clamp recordings (tight seal >15-25 GΩ) from CA3 pyramidal cells, hippocampal
slices were visualized with IR-DIC optics with an Axioskop 2FS equipped with Hamamatsu
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C2400-07E optics. The spontaneous EPSCs were recorded at a holding potential of -70 mV. The
intracellular solution contained 142.5 mM Cs-gluconate, 7.5 mM CsCl, 10 mM HEPES, 0.2 mM
EGTA, 2 mM Mg-ATP, 0.3 mM guanosine triphosphate (pH 7.4; 296 mOsm), 50 µM of AP5, 10
µM of Bicucculline. The currents were filtered at 5 kHz with a low-pass filter. Data were
digitized at a frequency of 10 kHz and stored online with the pclamp11 system (Axon
Instruments, Inc., Foster, CA). The input resistance and series resistance in postsynaptic
pyramidal cells were monitored with prevoltage steps (−2 mV; 100 ms) at 5 min intervals
throughout the period of the experiment. Series resistance ranged from 11 to 17 MΩ. Input
resistance was 346 ± 18 MΩ. Data are mean ± SEM (n = 8 cells/four animals)

Detection of GluR2 protein levels
The CA1 extracts (20 µg of protein) was obtained from rats 6h and 12h after they
underwent transient forebrain ischemia or sham. It was denatured with sodium dodecyl sulfate
sample buffer, separated by SDS-PolyAcrylamide Gel Electrophoresis on a 12% gel, transferred
into nitrocellulose membranes, and incubated with rabbit anti-GluR1 (1:500; Chemicon), antiGluR2 (1:200; Santa Cruz), anti-GluR3 (1: 200; Santa Cruz), antiGluR4 (1:500; Santa Cruz) and
anti-α-actin (1:1000; Chemicon). Immunoreactive bands were detected using an enhanced
Chemiluminescent kit (Amersham Biosciences) and quantified using Densitometer Quantity One
(Bio-Rad). Each reactive band was normalized to its respective sham (defined as 1.0). Data are
mean ± SEM (n = 4; *p < 0.01, compared to sham).
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Results
The numbers of functional AMPA channels do not change during ischemia
The electrophysiological recordings of the miniature EPSCsAMPA from CA1 pyramidal
neurons revealed that the mean amplitude of the miniature EPSCsAMPA in rats that were subjected
to transient forebrain ischemia was the same as that in sham animals (Fig. 19 a and b). These
results are consistent with previous reports that, although AMPA receptor channels are
permeable to Ca2+

32, 113, 186

, the EPSCsAMPA are not reduced

187, 188

. Because two distinct

GluR1/GluR2 and GluR3/GluR2 channels are located in CA1 pyramidal neurons

189-191

,

unchanged amplitudes of synaptic responses following reduced GluR2 gene expression could
result from over expression of GluR1 and GluR3 subunits.
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a

b

Figure 19. The mean amplitude of miniature EPSCsAMPA remain unchanged in CA1
pyramidal neurons following transient forebrain ischemia.
a) Sample traces of miniature EPSCsAMPA taken from CA1 pyramidal neurons in
hippocampal slices from rats 12 h after sham or transient forebrain ischemia. b) Averaged traces
of the miniature EPSCsAMPA from (a) are shown on the top. The mean amplitudes (pA) of the
responses are summarized in bar graph.
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GluR2 protein level is reduced by transient forebrain ischemia
We analyzed protein levels of AMPA receptor subunits in CA1 area of the hippocampus
from rats 12 h after transient forebrain ischemia. Western blots demonstrated that the GluR2
proteins in CA1 dorsal hippocampus were reduced by 38.8 ± 4.9% (n = 6; Fig. 20) compared to
sham control rats. Unlike the GluR2 subunit, protein levels of GluR1, GluR3, and GluR4
subunits in CA1 neurons following transient forebrain ischemia did not show a significant
change.

a

b

Figure 20. GluR2 proteins in CA1 hippocampus is reduced following transient forebrain
ischemia.
a) Representative Western blots of the CA1 cell lysates blotted with the indicated
antibodies. b) Summarized data are shown in the bar graph. (*p < 0.01)
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Conclusion
¾ The GluR2 subunit is a requisite for AMPA channel expression on the neuronal cell
surface. Hence, reduced GluR2 protein levels mean less number of channels on the cell
surface. However, this study shows that the amplitude of current flowing through the
AMPA receptors does not change during transient ischemia. This means the number of
functional AMPA channels do not change because of the ischemic insult.
¾ Previous data shows that when GluR2 Q/R site editing is impaired the unedited
transcripts accumulate in the nucleus reducing expressed GluR2 protein levels. Also, the
Ca2+/Zn2+ permeability of AMPA receptor channels is blocked by GluR2(R) Ca2+impermeable AMPA receptor channels, whereas the unedited GluR2(Q) allows Ca2+
entry through the channels. This study also shows that transient forebrain ischemia
reduces GluR2 protein levels. As the number of functional AMPA channels on the cell
surface is not reduced, we suggest that transient forebrain ischemia impairs GluR2 premRNA editing hence decreasing the number of unedited GluR2 transcripts and total
GluR2 protein levels. This increases the number of GluR2 (Q) channels on the cell
surface and in turn will increase the amount of Ca2+ entry into vulnerable neurons.
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Discussion
The Ca2+/Zn2+ permeability of AMPA receptor channels is dominated by the GluR2
subunit; an edited GluR2(R) forms Ca2+-impermeable AMPA receptor channels, whereas the
unedited GluR2(Q) allows Ca2+ entry through the channels

28, 29, 157-159, 161, 162

. Accordingly,

expression of Ca2+/Zn2+-permeable AMPA receptor channels in vulnerable CA1 neurons
following transient forebrain ischemia can simply result from reduced GluR2 gene expression, as
described earlier. Notably, delivery of GluR2 proteins from intracellular pools to the cell surface
is required for expression of functional AMPA receptor channels at CA1 synapses184,

185

.

Therefore, reduction of GluR2 protein levels should decrease the numbers of functional AMPA
receptor channels, as illustrated in Fig. 18a.
However, electrophysiological recordings of the miniature EPSCsAMPA from CA1
pyramidal neurons revealed that the mean amplitude of the miniature EPSCsAMPA in rats that
were subjected to transient forebrain ischemia was the same as that in sham animals (Fig. 18 b
and c). These results are consistent with previous reports that, although AMPA receptor channels
are permeable to Ca2+

32, 113

, the EPSCsAMPA are not reduced

187, 188

. Because two distinct

GluR1/GluR2 and GluR3/GluR2 channels are located in CA1 pyramidal neurons

189-191

,

unchanged amplitudes of synaptic responses following reduced GluR2 gene expression could
result from over expression of GluR1 and GluR3 subunits.
To address this question, we analyzed protein levels of AMPA receptor subunits in CA1
area of the hippocampus from rats after transient forebrain ischemia. Western blots demonstrated
that the GluR2 proteins in CA1 dorsal hippocampus were reduced while the GluR1, GluR3, and
GluR4 subunits protein levels was not changed. Together, we suggest that transient forebrain
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ischemia facilitates the events for incorporation of GluR2 subunits to plasma membrane. Under
this circumstance, although GluR2 gene expression is reduced, the numbers of functional AMPA
receptor channels remain unchanged.
Previous studies revealed that Q/R site unedited GluR2 easily exits the endoplasmic
reticulum and becomes the cell surface receptor channels

192, 193

. These findings implicate that

pre-mRNA editing of GluR2 at Q/R site could be impaired in vulnerable CA1 pyramidal neurons
following transient forebrain ischemia. Consistent with this hypothesis, recent studies have
demonstrated that impaired Q/R site editing contributes to selective motor neuronal death in
patients with amyotrophic lateral sclerosis

194, 195

. Gene-targeting studies demonstrated that the

deficits of GluR2 pre-RNA editing at Q/R site reduced GluR2 mRNA levels because of nuclear
accumulation of incompletely processed primary GluR2 transcripts

185

. Therefore, reduced

GluR2 mRNA levels observed in the CA1 area of the rat hippocampus following transient
forebrain ischemia may result from reduced Q/R site editing of GluR2 pre-mRNA. To address
this question, it is necessary to use single-cell reverse transcriptase polymerase chain reaction to
estimate GluR2 Q/R editing versus pre-mRNA accumulation in the nucleus of individual neurons
in the rat hippocampus.
To date, all clinical stroke trials targeting GluRs (AMPA or NMDA) have failed, possibly
because receptor antagonists also block the physiological actions of glutamate in uninjured
neurons

196, 197

. This work outlines a potential approach to selectively block the pathological

effects of AMPA receptors by targeting GluR2 subunit, thereby inhibiting only Ca2+/Zn2+
permeability. Thus, this approach should not affect the physiological actions of Ca2+/Zn2+impermeable AMPA receptors in uninjured neurons in the CNS. Therefore, this work may define
a promising target for stroke therapy. As reported
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194, 195

, a defect in GluR2 editing also

contributes to motor neuron death in amyotrophic lateral sclerosis. It is probable that a similar
therapeutic approach may apply to this disease.
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